Chronos Archive seal

Review checklist: Booker T. Washington (HR-NI017)

All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments

Everything a reviewer needs to judge, gathered from the record. Release status: draft.

Review status

ReviewStatusReviewerDateNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the outpatient handling of severe hypertension and the five-visit titration schedule.
provenance reviewnot_startedNPS biography, timeline, death bulletin, and news release logged; the 2006 conference is known only through the NPS bulletin; the birth date is uncertain.
safe messaging reviewnot_startedThe 1915 'racial characteristics' remark is flagged as sensitive and presented only with context; death recorded without graphic detail.

Judgment calls (dossier editorial resolutions)

  1. Birth date. Washington did not know his birth date. The National Park Service timeline gives April 5, 1856, which traces to his brother's report after his death; Washington himself estimated 1858 or 1859. The case uses April 5, 1856 as preferred, records 1858 or 1859 as a conflicting alternative, and keeps April 5 in the synthetic date of birth (1967-04-05).
  2. Index age and date. The modern episode presents Washington at 59, his age at the documented November 2, 1915 admission. That date cannot be used in the modern frame because the publication cutoff is November 1, 2026, and visits must also fall before his death on November 14 when shifted back by 111 years. The index visit is May 4, 2026 (true frame May 4, 1915), in the months of failing health the obituary describes, and the last visit is October 26, 2026 (true frame October 26, 1915). The 1915 admission and his death therefore fall after the index date and are left out of the past medical history; they remain in the historical timeline.
  3. Modern diagnosis. Bright's disease (1915) and malignant hypertension with kidney failure (2006 review, graded R) are linked to, but not equated with, the synthetic diagnosis of hypertensive chronic kidney disease stage G3b A3. The synthetic episode deliberately presents him earlier and without a hypertensive emergency, so outpatient treatment is appropriate; the intake blood pressure of 212/128 echoes, but is not, the documented 220/150.
  4. Biased attribution. Dr. Bastedo's 1915 “racial characteristics” remark and the syphilis rumor it fed are recorded as a sensitive claim (D) only with the negative Wassermann result and the 2006 review alongside them. The synthetic workup does not repeat syphilis testing.
  5. Sick and preventive visits. Two visits were added between the four-week and six-month reviews: an unscheduled sick visit on August 10, 2026 (true frame August 10, 1915) for an acute lumbar strain, and a periodic adult preventive visit on September 21, 2026 (true frame September 21, 1915). Both fall well before the November 1915 admission and are synthetic. He is 59, so the visit follows USPSTF adult preventive services rather than a Medicare wellness visit. The back strain does not echo a documented illness. It was chosen because self-treatment with an over-the-counter NSAID is a common and teachable hazard with losartan, a thiazide-like diuretic, and an SGLT2 inhibitor in stage G3b kidney disease; the same-day creatinine is kept unchanged from June so that the lesson is prevention rather than injury. The preventive visit keeps the care plan's decision not to repeat LDL, adapts the colonoscopy preparation to his kidney disease, and offers hepatitis C and HIV screening explicitly as universal one-time screens, not as risk-based tests; no syphilis testing is added, consistent with the decision above. The PSA discussion cites the USPSTF note on higher prostate cancer risk in Black men as a population statistic, not as an attribution about him. The PSA and the hepatitis C and HIV screens are ordered for the October draw and their results are not recorded. Its advance care planning names no real person as his health care agent.
  6. Focused visits. The four chronic-care follow-ups (one week, three weeks, four weeks, and six months) are documented as focused visits on the CMID hypertension and chronic kidney disease monographs, with the anemia-of-CKD items and the hyperlipidemia monograph where they apply. Each visit lists every item the protocols call for at that point, with its interval and status. The potassium and creatinine checks after each change fall in or before the window: one week after starting losartan (earlier than the CMID two to four weeks because of severe hypertension, within the care plan's one to four weeks), three weeks after the losartan increase and dapagliflozin start, and four weeks after chlorthalidone. Synthetic findings introduced: standardized office readings described as two-reading averages, an S4 on examination, undilated funduscopy at the one-week visit, interval home readings, symptoms, and travel details consistent with the existing record. Protocol deviations recorded instead of invented results: no urinalysis with microscopy from the diagnostic workup (not repeated later because his status did not change); no kidney failure risk calculation before the nephrology referral (first calculated at six months); and no baseline 25-hydroxyvitamin D, planned for the six-month draw and still not drawn then. No harm is evident from any of them. The lipid monograph's 4 to 12 week and yearly lipid panels are recorded as not indicated, a deliberate departure that follows the CKD monograph and KDIGO and the care plan's existing decision not to repeat LDL. The six-month note says that the PSA and hepatitis C and HIV screens ordered at the preventive visit were added to that draw; their results are not recorded.
  7. Consultation. The nephrology referral and Dr. Oyelaran's consultation on the day of the one-week visit are synthetic and are written to agree with the record: the losartan increase, dapagliflozin start, vaccinations, the later chlorthalidone step, and the six-month results sent back to nephrology. Synthetic details introduced: no abdominal bruit on examination and a symmetric description of the recorded ultrasound. Judgment calls: (1) urinalysis with microscopy and any further workup for other kidney diseases are made conditional on albuminuria not falling, matching the deviation and corrective action recorded at the visit; albuminuria later fell by 71 percent; (2) secondary-hypertension testing is reserved for blood pressure above target on three agents, which did not occur; (3) the kidney failure risk is deferred until eGFR settles, matching its first calculation at six months; (4) consistent with the decisions above, the consultation adds no syphilis testing and no race-based testing or attribution, and the hepatitis C and HIV screens stay with the preventive visit.
  8. Mother's death. The NPS release gives 1876; other accounts give 1874. The case uses 1876 with that caveat and records no cause.
  9. Not used. His father was an unidentified white man, so no paternal history is recorded. His wives' deaths are not family medical history. His children's later illnesses happened after the index date and are not recorded. A 2006 statement that he died of hypertensive cardiomyopathy and nephrosclerosis appeared in search summaries but was not confirmed in a fetched source and is not used.
  10. Washington died in 1915, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required.

Protocol deviations

Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.

VisitMeasureIntervalWhat happened
2026-05-11
Progress note 02 (C-CDA)
Urinalysis with microscopyAt diagnosis, then with a change in statusNot on file from the diagnostic workup, a deviation from the protocol. It screens for blood or casts that would point away from hypertensive nephrosclerosis. Today's ultrasound and the history fit hypertensive kidney disease, so no harm is evident. Corrective action: obtain it if albuminuria does not fall on treatment or kidney function changes unexpectedly
2026-05-11
Progress note 02 (C-CDA)
Kidney failure risk equation, 2 and 5 yearsYearly in G3 to G5; before referral decisionsNot calculated before the nephrology referral, a deviation from the protocol. The referral stood on other criteria (eGFR below 60 with severely increased albuminuria), so no harm resulted. Corrective action: calculate at the six-month review, once eGFR has settled on full therapy
2026-10-26
Progress note 07 (C-CDA)
25-hydroxyvitamin DOnce at baselineNot drawn at diagnosis or with today's calcium, phosphate, and PTH, a deviation from the protocol. PTH is falling with normal calcium and phosphate, so no harm is evident. Corrective action: added to the next draw

Orders and referrals without results in the record

VisitTypeItemStatusDetail
2026-09-21
Progress note 06 (C-CDA)
PreventionColorectal cancer screeningReferredNo prior screening on record; he chose colonoscopy. Referral sent with a request for a polyethylene glycol preparation and no sodium phosphate preparation, because of his kidney disease; hold dapagliflozin and chlorthalidone on the preparation day
2026-09-21
Progress note 06 (C-CDA)
PreventionProstate cancer screeningOrderedShared decision-making about benefits, false positives, and overdiagnosis, including the higher prostate cancer risk among Black men described in the USPSTF statement. He chose PSA testing; added to the October blood draw
2026-09-21
Progress note 06 (C-CDA)
PreventionHepatitis C and HIV screeningOrderedOne-time screening offered to all adults in these age ranges, not based on any individual risk; no prior result on record; added to the October blood draw

Evidence to check

Retrospective claims (R)

ClaimStatementCertainty
CLM-0009A 2006 historical clinicopathological conference at the University of Maryland School of Medicine reviewed his hospital record and concluded that he presented with malignant hypertension that caused kidney failure.probable

Sensitive claims

ClaimGradeStatement
CLM-0010DA 1915 remark by Dr. Bastedo attributing the death partly to 'racial characteristics' was read by Washington's Chicago physician, Dr. George C. Hall, as implying syphilis; the hospital Wassermann test was negative, and the 2006 review did not support that explanation.

Diagnoses not confirmed

None.

Notes to read

Every note in the record, with its type. All clinical content is synthetic.

Abnormal results

DateResultValueFlag
2026-05-04Bicarbonate (total CO2)21 mmol/L (low)Low
2026-05-04BUN34 mg/dL (high)High
2026-05-04Creatinine2.1 mg/dL (high)High
2026-05-04eGFR36 mL/min/1.73 m² (low)Low
2026-05-04Intact PTH92 pg/mL (high)High
2026-05-04Hemoglobin12.6 g/dL (low)Low
2026-05-04LDL cholesterol138 mg/dL (high)High
2026-05-04Urine albumin-creatinine ratio820 mg/g (high)High
2026-05-11BUN36 mg/dL (high)High
2026-05-11Creatinine2.2 mg/dL (high)High
2026-05-11eGFR34 mL/min/1.73 m² (low)Low
2026-06-01BUN38 mg/dL (high)High
2026-06-01Creatinine2.4 mg/dL (high)High
2026-06-01eGFR30 mL/min/1.73 m² (low)Low
2026-06-29BUN36 mg/dL (high)High
2026-06-29Creatinine2.4 mg/dL (high)High
2026-06-29eGFR30 mL/min/1.73 m² (low)Low
2026-06-29Urine albumin-creatinine ratio360 mg/g (high)High
2026-10-26BUN34 mg/dL (high)High
2026-10-26Creatinine2.3 mg/dL (high)High
2026-10-26eGFR32 mL/min/1.73 m² (low)Low
2026-10-26Intact PTH78 pg/mL (high)High
2026-10-26Hemoglobin12.8 g/dL (low)Low
2026-10-26Urine albumin-creatinine ratio240 mg/g (high)High
2026-08-10BUN37 mg/dL (high)High
2026-08-10Creatinine2.4 mg/dL (high)High
2026-08-10eGFR30 mL/min/1.73 m² (low)Low